Mark Currie
Net worth: 2 M $ as of 31/05/2026
Net worth: 2 M $ as of 31/05/2026
Mark G.
Currie currently works at Science Exchange, Inc., as Director from 2020, Antag Therapeutics ApS, as Director, Sea Pharmaceuticals LLC, as Director from 2021, Ironwood Pharmaceuticals, Inc., as Independent Director from 2019, and Iaso Ventures LP, as Partner.
Dr. Currie also formerly worked at Monsanto Co., as Director-Arthritis & Inflammation, G.D.
Searle & Co., Inc., as Director-Arthritis & Inflammation, Sumitomo Pharma America, Inc., as Vice President-Discovery Research from 1999 to 2002, Ironwood Pharmaceuticals, Inc., as Chief Scientific Officer, President-R&D, Senior VP from 2002 to 2019, and Cyclerion Therapeutics, Inc., as President & Chief Scientific Officer from 2019 to 2020.
Dr. Currie received his doctorate degree from Wake Forest School of Medicine and undergraduate degree from the University of South Alabama.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/06/2026 | 676,900 ( 0.41% ) | 2 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Director/Board Member | 01/01/2019 |
Science Exchange, Inc.
Science Exchange, Inc. Packaged SoftwareTechnology Services Provides life sciences procurement and supplier management SaaS solutions for biotech companies | Director/Board Member | 12/02/2020 |
Sea Pharmaceuticals LLC
Sea Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Operates as a neurotherapeutics research and development company | Director/Board Member | 01/02/2021 |
Antag Therapeutics ApS
Antag Therapeutics ApS Medical/Nursing ServicesHealth Services Provides obesity, diabetes and overweight therapy services | Director/Board Member | - |
Iaso Ventures LP
Iaso Ventures LP Investment ManagersFinance Functions as a venture capital fund | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | President | 01/12/2020 |
| IRONWOOD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/03/2019 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 01/08/2002 |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Corporate Officer/Principal | - |
| ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Monsanto Co.
Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Wake Forest School of Medicine
Wake Forest School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Process Industries |
University of South Alabama
University of South Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Science Exchange, Inc.
Science Exchange, Inc. Packaged SoftwareTechnology Services Provides life sciences procurement and supplier management SaaS solutions for biotech companies | Technology Services |
Sea Pharmaceuticals LLC
Sea Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Operates as a neurotherapeutics research and development company | Commercial Services |
Antag Therapeutics ApS
Antag Therapeutics ApS Medical/Nursing ServicesHealth Services Provides obesity, diabetes and overweight therapy services | Health Services |
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Iaso Ventures LP
Iaso Ventures LP Investment ManagersFinance Functions as a venture capital fund | Finance |
Select your edition
All financial news and data tailored to specific country editions